Aspira Pathlab Stock Screener | Share Price & Fundamental Analysis
ASPIRA
Healthcare Service Provider
Share Price BSE
₹61.80
▲
1.80 (3.00%)
Track Aspira Pathlab share price live with TickJournal's free stock screener.
Analyze Aspira Pathlab share price history trends and compare 52-week high low
levels.
Calculate ASPIRA stock fair value using fundamental analysis and view live share price charts.
Determine Aspira Pathlab share intrinsic value and compare it with current ASPIRA share price.
Record your Aspira Pathlab trades in TickJournal's free trading journal and track your portfolio performance.
Aspira Pathlab Market Cap
₹62.56 Cr.
ASPIRA P/E Ratio (TTM)
26.32
EPS (TTM)
₹1.97
Dividend Yield
-
Debt to Equity
0.15
ASPIRA 52 Week High
₹101.70
Aspira Pathlab 52 Week Low
₹51.52
Operating Margin
13.00%
Profit Margin
-
ASPIRA Revenue (TTM)
₹5.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹18.00
Total Equity
₹12.00
Aspira Pathlab Share Price History - Stock Screener Chart
Screen ASPIRA historical share price movements with interactive charts. Analyze price trends and patterns.
Aspira Pathlab Company Profile - Fundamental Screener
Screen Aspira Pathlab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ASPIRA shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE500C01017
Aspira Pathlab Balance Sheet Screener
Screen ASPIRA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Total Assets | 18 | 15 |
| Current Assets | 5 | 4 |
| Fixed Assets | 7 | 7 |
| Liabilities | ||
| Total Liabilities | 18 | 15 |
| Current Liabilities | 3 | 3 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 12 | 10 |
| Share Capital | 10 | 10 |
| Reserves & Surplus | -3 | -5 |
Aspira Pathlab Income Statement Screener - Profit & Revenue Analysis
Screen Aspira Pathlab income statement and profit fundamentals.
Analyze ASPIRA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Aspira Pathlab share price evaluation.
| Item | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Jun |
|---|---|---|---|---|---|---|---|
| Revenue | 5 | 6 | 6 | 6 | 5 | 4 | 3 |
| Expenses | 5 | 5 | 5 | 5 | 4 | 4 | 3 |
| EBITDA | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Operating Profit % | 13.00% | 16.00% | 11.00% | 21.00% | 6.00% | -5.00% | -17.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 0 | 1 | 0 | -1 | -1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 0 | 1 | 0 | -1 | -1 |
| EPS | 0.41 | 0.66 | 0.30 | 0.96 | 0.05 | -0.49 | -0.70 |
Aspira Pathlab Cash Flow Screener - Liquidity Fundamentals
Screen ASPIRA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | 2 | 1 |
| Investing Activities | 0 | 0 |
| Financing Activities | -1 | -1 |
| Net Cash Flow | 1 | 0 |
Aspira Pathlab Shareholding Pattern Screener
See Aspira Pathlab shareholding pattern with promoter, FII, and DII holdings.
Check Aspira Pathlab promoter holding and ownership changes for ASPIRA on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 18.39% | 18.39% | 18.39% | 18.39% | 18.55% | 18.55% | 18.72% | 18.72% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 60.07% | 60.16% | 60.28% | 60.46% | 60.28% | 61.26% | 59.15% | 55.71% |
| Other Holding | 21.54% | 21.45% | 21.33% | 21.15% | 21.18% | 20.19% | 22.13% | 25.57% |
| Shareholder Count | 1,784 | 1,755 | 1,770 | 1,741 | 1,593 | 1,706 | 1,695 | 1,512 |
Aspira Pathlab Share Dividend Screener - Share Yield Analysis
Check Aspira Pathlab dividend history with payout and yield data.
View Aspira Pathlab dividend details including ex-dates and amounts for ASPIRA stock.
Aspira Pathlab Stock Index Membership
See which indices include Aspira Pathlab stock.
Check ASPIRA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Aspira Pathlab Market Events Screener - Corporate Actions
Get Aspira Pathlab corporate actions including splits, bonuses, and buybacks.
Check Aspira Pathlab stock events that may affect ASPIRA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 27.67% | ||
| Annual General Meeting | NA | -1.79% | ||
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | 13.68% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -0.33% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -6.20% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | -12.33% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | -9.00% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 23.16% |
| 2016-11-16 | 2016-11-16 | Change Of Name | NA | - |
Aspira Pathlab Competitors Screener - Peer Comparison
Screen ASPIRA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 23,435 | 45.08 | 2,555 | 11.28% | 492 | 43.51 |
| Vijaya Diagnostic Centre | 10,150 | 67.35 | 700 | 23.06% | 144 | 49.38 |
| Metropolis Healthcare | 10,094 | 60.71 | 1,346 | 10.64% | 146 | 52.68 |
| Thyrocare Technologies | 6,416 | 47.08 | 702 | 20.80% | 91 | 38.76 |
| Nephrocare Health Services | 5,747 | 80.98 | 770 | 33.97% | 67 | 69.85 |
| Krsnaa Diagnostics | 2,169 | 27.26 | 743 | 16.70% | 78 | 34.08 |
| Suraksha Diagnostic | 1,485 | 45.82 | 256 | 15.11% | 31 | 60.68 |
| One Global Service Provider | 1,466 | 31.90 | 148 | 134.60% | 19 | 73.28 |
| 3B BlackBio DX | 1,368 | 24.24 | 112 | 28.72% | 48 | 50.92 |
| Sastasundar Ventures | 939 | 31.81 | 1,171 | -18.47% | -134 | 45.34 |
Aspira Pathlab Company Announcements - News Screener
Screen ASPIRA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-18 | Unaudited Standalone Financial Results & Limited Review Report For Quarter Ended December 31 2025 | View |
| 2026-02-18 | Board Meeting Outcome for Outcome Of The Board Meeting For The Approval Of Unaudited Standalone Financial Results For 31.12.2025 | View |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2026-02-14 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2026-02-12 | Board Meeting Intimation for Approval Of Unaudited Standalone Financial Results Alongwith Limited Review Report For The Quarter & Nine Months Ended As On December 31 2025. | View |
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-06 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2026-01-05 | Announcement under Regulation 30 (LODR)-Demise | View |
| 2026-01-02 | Announcement under Regulation 30 (LODR)-Demise | View |
| 2025-12-29 | Closure of Trading Window | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-11-12 | Standalone Financial Results And Limited Review Report As On September 30 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On November 12 2025 | View |
| 2025-11-04 | Board Meeting Intimation for The Board Meeting To Be Held On November 12 2025 | View |
| 2025-10-13 | Announcement under Regulation 30 (LODR)-Open Offer - Updates | View |
| 2025-10-13 | Draft Letter of Offer | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |